Lietuva -
lietuvių -
SMCA (Valstybinė vaistų kontrolės tarnyba)
zmax
pfizer europe ma eeig - azitromicinas - pailginto atpalaidavimo granulės geriamajai suspensijai - 2 g - azithromycin
Lietuva -
lietuvių -
SMCA (Valstybinė vaistų kontrolės tarnyba)
flixonase
glaxosmithkline dungarvan limited - flutikazono propionatas - nosies purškalas (suspensija) - 50 µg/išpurškime - fluticasone
Europos Sąjunga -
lietuvių -
EMA (European Medicines Agency)
sarclisa
sanofi winthrop industrie - isatuximab - daugybinė mieloma - antinavikiniai vaistai - sarclisa is indicated: in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma (mm) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (pi) and have demonstrated disease progression on the last therapy. in combination with carfilzomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy (see section 5.